Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsDoxorubicinCisplatinCell Line, TumorDrug Resistance, NeoplasmDrug Screening Assays, AntitumorEmployer Health CostsNeoplasmsEtoposideApoptosisAntineoplastic Agents, PhytogenicPaclitaxelChemotherapy, AdjuvantCell SurvivalPrescription FeesDrug Delivery SystemsTumor Cells, CulturedAntibiotics, AntineoplasticBreast NeoplasmsFluorouracilXenograft Model Antitumor AssaysDose-Response Relationship, DrugCell ProliferationCombined Modality TherapyDrug SynergismOvarian NeoplasmsCyclophosphamideGene Expression Regulation, NeoplasticMice, NudeAntineoplastic Agents, AlkylatingTreatment OutcomeAntimetabolites, AntineoplasticDrug Resistance, MultipleLung NeoplasmsVinblastineP-GlycoproteinDeoxycytidineNeoplasm TransplantationMethotrexateTaxoidsCamptothecinDrug Administration ScheduleBleomycinDaunorubicinCarboplatinNeoplasms, ExperimentalOrganoplatinum CompoundsNeoadjuvant TherapyDisease-Free SurvivalMitomycinSurvival AnalysisProto-Oncogene Proteins c-bcl-2Time FactorsAdenocarcinomaPrognosisTumor Suppressor Protein p53Inhibitory Concentration 50Neoplasm StagingColonic NeoplasmsCytarabineDacarbazineMice, Inbred BALB CSurvival RateCarmustineMice, SCIDMitoxantroneCell CycleNeoplasm MetastasisLiver NeoplasmsDrug ResistanceMelanoma, ExperimentalBrain NeoplasmsCaspasesDNA DamageMelphalanAntibodies, MonoclonalOsteosarcomaTransplantation, HeterologousCarcinoma, Non-Small-Cell LungImmunotherapyFlow CytometryRNA, Small InterferingNeoplasm ProteinsCell DivisionLeukemia P388Tumor BurdenBlotting, WesternMelanomaSignal TransductionNeoplasm Recurrence, LocalColorectal NeoplasmsIfosfamideApoptosis Regulatory ProteinsCaspase 3VincristineDrug CarriersAnthracyclinesCell DeathMultidrug Resistance-Associated Proteins